REMSleep Holdings, Inc. (RMSL)
USD 0.01
(0.55%)
USD 0.01
(0.55%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -540.98 Thousand USD | 61.12% |
| 2022 | -1.39 Million USD | 53.09% |
| 2021 | -2.96 Million USD | -1919.23% |
| 2020 | 163.04 Thousand USD | -15.6% |
| 2019 | 193.16 Thousand USD | -27.24% |
| 2018 | 265.5 Thousand USD | 453.29% |
| 2017 | 47.98 Thousand USD | -43.74% |
| 2016 | 85.29 Thousand USD | -2.09% |
| 2015 | 87.11 Thousand USD | -90.12% |
| 2014 | 881.32 Thousand USD | -62.81% |
| 2013 | 2.36 Million USD | 495912.76% |
| 2012 | -478.00 USD | 92.42% |
| 2011 | -6309.00 USD | -100.82% |
| 2010 | 773.04 Thousand USD | 4143.51% |
| 2009 | 18.21 Thousand USD | 512.95% |
| 2008 | 2972.00 USD | 941.93% |
| 2007 | -353.00 USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -528.17 Thousand USD | 2.37% |
| 2024 Q2 | -498 Thousand USD | 5.71% |
| 2023 Q1 | -1.13 Million USD | 18.33% |
| 2023 Q4 | -540.98 Thousand USD | 22.94% |
| 2023 Q2 | -856.13 Thousand USD | 24.66% |
| 2023 Q3 | -702.06 Thousand USD | 18.0% |
| 2023 FY | -540.98 Thousand USD | 61.12% |
| 2022 Q1 | -3.75 Million USD | -26.45% |
| 2022 Q4 | -1.39 Million USD | 17.53% |
| 2022 FY | -1.39 Million USD | 53.09% |
| 2022 Q3 | -1.68 Million USD | 10.86% |
| 2022 Q2 | -1.89 Million USD | 49.55% |
| 2021 Q2 | 78.85 Thousand USD | -64.94% |
| 2021 Q4 | -2.96 Million USD | -47.17% |
| 2021 Q3 | -2.01 Million USD | -2655.8% |
| 2021 Q1 | 224.94 Thousand USD | 37.96% |
| 2021 FY | -2.96 Million USD | -1919.23% |
| 2020 Q2 | 294.8 Thousand USD | 132.12% |
| 2020 Q4 | 163.04 Thousand USD | -9.69% |
| 2020 Q3 | 180.54 Thousand USD | -38.76% |
| 2020 FY | 163.04 Thousand USD | -15.6% |
| 2020 Q1 | 127 Thousand USD | -34.25% |
| 2019 Q1 | 260.16 Thousand USD | -2.01% |
| 2019 FY | 193.16 Thousand USD | -27.24% |
| 2019 Q2 | 125.07 Thousand USD | -51.93% |
| 2019 Q3 | 257.52 Thousand USD | 105.9% |
| 2019 Q4 | 193.16 Thousand USD | -24.99% |
| 2018 Q4 | 265.5 Thousand USD | 32.11% |
| 2018 Q3 | 200.97 Thousand USD | 352.16% |
| 2018 FY | 265.5 Thousand USD | 453.29% |
| 2018 Q2 | 44.44 Thousand USD | 2065.81% |
| 2018 Q1 | -2261.00 USD | -104.71% |
| 2017 Q1 | 104.72 Thousand USD | 109.44% |
| 2017 Q3 | 163.4 Thousand USD | 19.06% |
| 2017 Q2 | 137.24 Thousand USD | 31.06% |
| 2017 FY | 47.98 Thousand USD | -43.74% |
| 2017 Q4 | 47.98 Thousand USD | -70.63% |
| 2016 FY | 85.29 Thousand USD | -2.09% |
| 2016 Q2 | 113.19 Thousand USD | 2.78% |
| 2016 Q4 | 50 Thousand USD | -55.83% |
| 2016 Q3 | 113.21 Thousand USD | 0.01% |
| 2016 Q1 | 110.14 Thousand USD | 26.44% |
| 2015 Q3 | 174.78 Thousand USD | 0.0% |
| 2015 FY | 87.11 Thousand USD | -90.12% |
| 2015 Q4 | 87.11 Thousand USD | -50.16% |
| 2015 Q2 | 174.78 Thousand USD | 28.14% |
| 2015 Q1 | 136.4 Thousand USD | -84.52% |
| 2014 FY | 881.32 Thousand USD | -62.81% |
| 2014 Q1 | 820.04 Thousand USD | -65.4% |
| 2014 Q4 | 881.32 Thousand USD | -0.98% |
| 2014 Q3 | 890 Thousand USD | -0.01% |
| 2014 Q2 | 890.04 Thousand USD | 8.54% |
| 2013 Q2 | 49.85 Thousand USD | 7221.43% |
| 2013 Q3 | 50.01 Thousand USD | 0.32% |
| 2013 Q4 | 2.36 Million USD | 4638.93% |
| 2013 FY | 2.36 Million USD | 495912.76% |
| 2013 Q1 | -700.00 USD | -46.44% |
| 2012 Q1 | -3776.00 USD | 40.15% |
| 2012 Q4 | -478.00 USD | 97.45% |
| 2012 Q3 | -18.76 Thousand USD | 19.8% |
| 2012 FY | -478.00 USD | 92.42% |
| 2012 Q2 | -23.39 Thousand USD | -519.47% |
| 2011 Q4 | -6309.00 USD | 83.59% |
| 2011 Q2 | - USD | -100.0% |
| 2011 Q1 | 791.99 Thousand USD | 2.45% |
| 2011 Q3 | -38.45 Thousand USD | 0.0% |
| 2011 FY | -6309.00 USD | -100.82% |
| 2010 Q2 | - USD | -100.0% |
| 2010 Q4 | 773.04 Thousand USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q1 | 19.3 Thousand USD | 5.98% |
| 2010 FY | 773.04 Thousand USD | 4143.51% |
| 2009 Q3 | 9122.00 USD | 2.82% |
| 2009 Q1 | 8372.00 USD | 181.7% |
| 2009 FY | 18.21 Thousand USD | 512.95% |
| 2009 Q4 | 18.21 Thousand USD | 99.7% |
| 2009 Q2 | 8872.00 USD | 5.97% |
| 2008 Q3 | 5472.00 USD | -8.37% |
| 2008 Q1 | -15.6 Thousand USD | -4320.11% |
| 2008 FY | 2972.00 USD | 941.93% |
| 2008 Q4 | 2972.00 USD | -45.69% |
| 2008 Q2 | 5972.00 USD | 138.27% |
| 2007 Q3 | - USD | 0.0% |
| 2007 FY | -353.00 USD | 0.0% |
| 2007 Q4 | -353.00 USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| BioElectronics Corporation | 14.82 Million USD | 103.649% |
| Medical Supply International USA, Inc. | 216.6 Thousand USD | 349.753% |
| Polarean Imaging plc | -5.94 Million USD | 90.903% |
| Avitar, Inc. | 5.17 Million USD | 110.462% |
| CVR Medical Corp. | - USD | Infinity% |
| IR-Med Inc. | -606 Thousand USD | 10.728% |
| AVITA Medical, Inc. | -26.23 Million USD | 97.938% |
| Manhattan Scientifics, Inc. | -7000.00 USD | -7628.371% |
| Össur hf. | 395.08 Million USD | 100.137% |
| Zecotek Photonics Inc. | 2.76 Million USD | 119.584% |
| QHSLab, Inc. | 1.72 Million USD | 131.271% |
| Wellstar International, Inc. | 51.36 Million USD | 101.053% |
| Össur hf. | 395.08 Million USD | 100.137% |
| Bionovate Technologies Corp | - USD | Infinity% |
| EKF Diagnostics Holdings plc | -4.61 Million USD | 88.283% |
| Escalon Medical Corp. | 315.68 Thousand USD | 271.368% |
| Aurora Spine Corporation | 1.9 Million USD | 128.359% |
| BrainsWay Ltd. | -10.32 Million USD | 94.758% |
| Lattice Biologics Ltd. | - USD | Infinity% |
| NewCardio, Inc. | 2.41 Million USD | 122.401% |
| Hamilton Thorne Ltd. | 18.12 Million USD | 102.985% |
| Vivos Inc. | -1.59 Million USD | 66.025% |
| MicroPort Scientific Corporation | 673.58 Million USD | 100.08% |
| Kelyniam Global, Inc. | 487.33 Thousand USD | 211.01% |
| CYduct Diagnostics, Inc. | 640.19 Thousand USD | 184.503% |
| Nanomix Corporation | 11.38 Million USD | 104.75% |
| Theraclion SA | -5.86 Million EUR | 90.775% |
| Lifeline Biotechnologies, Inc. | - USD | Infinity% |
| Wellness Center USA, Inc. | 3.98 Million USD | 113.574% |
| Positron Corporation | 1.68 Million USD | 132.07% |
| Rafina Innovations Inc. | - USD | Infinity% |
| Electromedical Technologies, Inc. | 1.61 Million USD | 133.584% |
| Lombard Medical, Inc. | 11.49 Million USD | 104.706% |
| ALR Technologies Inc. | 19.14 Million USD | 102.825% |
| Stratec SE | 119.12 Million USD | 100.454% |
| Vycor Medical, Inc. | 1.05 Million USD | 151.378% |
| Heart Tronics, Inc. | 54.99 Thousand USD | 1083.7% |
| Nu-Med Plus, Inc. | 93.19 Thousand USD | 680.494% |
| Perimeter Medical Imaging AI, Inc. | -13.78 Million USD | 96.076% |
| SANUWAVE Health, Inc. | 30.14 Million USD | 101.794% |
| VMS Rehab Systems, Inc. | 133.52 USD | 405272.259% |
| Guided Therapeutics, Inc. | 1.46 Million USD | 136.877% |
| Ingen Technologies, Inc. | 630.91 Thousand USD | 185.746% |
| Odyssey Group International, Inc. | 2.1 Million USD | 125.666% |
| United American Healthcare Corporation | -9.32 Million USD | 94.2% |
| ECGI Holdings, Inc. | 3.17 Million USD | 117.059% |
| Capital Group Holdings, Inc. | -3508.00 USD | -15321.494% |
| ADM Tronics Unlimited, Inc. | 262.61 Thousand USD | 305.997% |
| Urologix, Inc. | 4.61 Million USD | 111.722% |
| Rapid Therapeutic Science Laboratories, Inc. | 4.2 Million USD | 112.852% |
| Nexeon MedSystems Inc. | 3.33 Million USD | 116.24% |
| SS Innovations International, Inc. | 1.18 Million USD | 145.64% |
| Qualis Innovations, Inc. | 6671.00 USD | 8209.519% |
| Smith & Nephew plc | 2.77 Billion USD | 100.019% |
| NIOX Group Plc | -23.93 Million USD | 97.74% |
| Fuse Medical, Inc. | 1.75 Million USD | 130.817% |
| Broncus Holding Corporation | -81.42 Million USD | 99.336% |
| Brain Scientific Inc. | 2.11 Million USD | 125.569% |
| Pressure BioSciences, Inc. | 22.67 Million USD | 102.386% |
| Health Logic Interactive Inc. | 39.55 Thousand USD | 1467.611% |